Administration of Fenofibrate Markedly ElevatesFabp3in Rat Liver and Plasma and Confounds Its Use as a Preclinical Biomarker of Cardiac and Muscle Toxicity-Reference-Cited by-同舟云学术

Administration of Fenofibrate Markedly ElevatesFabp3in Rat Liver and Plasma and Confounds Its Use as a Preclinical Biomarker of Cardiac and Muscle Toxicity

Published:2018-10 Issue:10 Volume:53 Page:947-960
ISSN:0024-4201
Container-title:Lipids
language:en
Short-container-title:Lipids

Author:

Kochansky Christopher J.¹²,Lyman Michael J.¹,Fauty Scott E.³,Vlasakova Katerina³,D'mello Anil P.²

Affiliation:

1. Pharmacokinetics, Pharmacodynamics and Drug Metabolism; Merck & Co., Inc.; 770 Sumneytown Pike, WP75A-203A, West Point PA 19486 USA

2. Department of Pharmaceutical Sciences; University of the Sciences in Philadelphia; 600 South 43rd Street, Philadelphia PA 19104-4495 USA

3. Safety Assessment; Merck & Co., Inc.; 770 Sumneytown Pike, WP81-217, West Point PA 19486 USA

Publisher

Wiley

Subject

Cell Biology,Organic Chemistry,Biochemistry

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/lipd.12110/fullpdf

Reference72 articles.

1. Regulation of triglyceride metabolism by PPAR: Fibrates and thiazolidinediones have distinct effects;Auwerx;Journal of Atherosclerosis and Thrombosis,1996

2. The mechanisms of action of PPAR;Berger;Annual Review of Medicine,2002

3. Regulatable fatty acid transport mechanisms are central to the pathophysiology of obesity, fatty liver, and metabolic syndrome;Berk;Hepatology,2008

4. Requirement for the heart-type fatty acid binding protein in cardiac fatty acid utilization;Binas;FASEB Journal: Official Publication of the Federation of American Societies for Experimental Biology,1999

5. Exploration of PPAR functions by microarray technology-A paradigm for nutrigenomics;Bunger;Biochimica et Biophysica Acta,2007

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Pathology in Nonclinical Toxicity Studies;A Comprehensive Guide to Toxicology in Nonclinical Drug Development;2024

2. Interpretation of Clinical Pathology Results in Nonclinical Toxicity Testing;Haschek and Rousseaux's Handbook of Toxicologic Pathology, Volume 2 : Safety Assessment Environmental Toxicologic Pathology;2023

3. Scientific and Regulatory Policy Committee Points to Consider: Integration of Clinical Pathology Data With Anatomic Pathology Data in Nonclinical Toxicology Studies;Veterinary Clinical Pathology;2022-08-17

4. Scientific and Regulatory Policy Committee Points to Consider: Integration of Clinical Pathology Data With Anatomic Pathology Data in Nonclinical Toxicology Studies;Toxicologic Pathology;2022-08

5. Myokines as biomarkers of frailty and cardiovascular disease risk in females;Experimental Gerontology;2020-05